Protocol summary

Study aim
Comparison of the effect of intrathecal addition of dexmedetomidine and sufentanil to bupivacaine in patients undergoing knee prosthesis by spinal anesthesia
Design
double-blind randomized clinical trial, phase 3 on 90 patients, web-based randomization software was used for randomization.
Settings and conduct
The present study is a double-blind clinical trial that will be performed on patients aged 40 to 70 years referred to Imam Ali (AS) Teaching Hospital in Bojnourd. Patients are randomly assigned to three groups (two interventions and control) blocked by a web-based system. The level and duration of analgesia will be assessed by a measuring instrument. To perform blinding, patients and the person performing the pain assessment work at different intervals will be blinded to the groups.
Participants/Inclusion and exclusion criteria
Inclusion criteria: Patients be vigilant. Do not Have history of previous surgery. Do not Have history of taking anti-anxiety, analgesic and sedative drugs. Do not Have history of allergies to drugs used in the study. Patients should be between 40 and 70 years old. Exclusion criteria: Patients undergoing general anesthesia for any reason after spinal anesthesia.
Intervention groups
In the first group, patients in combination with the main drug (bupivacaine); They will receive 10 micrograms of intrathecal dexmedetomidine. In the second group, patients in combination with the main drug (bupivacaine); will receive micrograms of intrathecal sufentanil. In the third group, patients will receive only bupivacaine.
Main outcome variables
Level and duration of analgesia

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20141001019359N12
Registration date: 2022-04-08, 1401/01/19
Registration timing: prospective

Last update: 2022-04-08, 1401/01/19
Update count: 0
Registration date
2022-04-08, 1401/01/19
Registrant information
Name
Hossein Zeraati
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 58 3151 0000
Email address
zeraatih911@mums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2022-05-22, 1401/03/01
Expected recruitment end date
2023-01-20, 1401/10/30
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison of the effect of Intrathecal addition of Dexmedetomidine and Sufentanil to Bupivacaine in Patients Undergoing Knee Prosthesis under Spinal Anesthesia: a Double-blind Randomized Clinical Trial
Public title
Comparison of the effect of Intrathecal addition of Dexmedetomidine and Sufentanil to Bupivacaine in Patients Undergoing Knee Prosthesis
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Be vigilant Do not Have history of previous surgery, Do not Have history of taking anti-anxiety, analgesic and sedative drugs Do not Have history of allergies to drugs used in the study Do not have drug addiction. Age between 40 to 70 years
Exclusion criteria:
Patients undergoing general anesthesia for any reason after spinal anesthesia
Age
From 40 years old to 70 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Outcome assessor
  • Data analyser
Sample size
Target sample size: 90
Randomization (investigator's opinion)
Randomized
Randomization description
Sampling in this study will be that first in order to enter the study patients will be in the form of non-random sampling of the type "available" and then divide them into three intervention groups by randomly assigned blocking using a web-based system. Random blocking at www.randomization.com will be done in 15 blocks of 6. So that in each block, there are 2 people in the first group (A), two people in the second group (B) and two people in the third group (C). After a random sequence was identified in all blocks, cards were written by writing C, B, and A to indicate which group each patient was assigned to, and by someone other than the research team from 1 to 90 in all blocks, respectively. They are numbered and these cards are placed in sealed non-transparent envelopes, respectively. Then, in order to hide the random allocation, when the patient visits, the opaque sealed envelope will be opened and then one by one, it will be determined for each sample of the relevant group.
Blinding (investigator's opinion)
Double blinded
Blinding description
None of the participants in the study will be aware of the randomization list, and in order to conceal the randomization process, the groups will be placed in closed envelopes in the reception area and will be assigned to the eligible individuals who enter the study. Participants also referred to the type of intervention (drugs in the syringe for injection into the intrathecal space) because the syringes had already been diluted to the same volume; And the position of the patients will not be known during the spinal anesthesia technique. Therefore, the study is double-blind so that patients and the outcome assessment specialist are unaware of the status of the three groups assigned to the study.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of North Khorasan University of Medical Sciences
Street address
Vice Chancellor for Research of North Khorasan University of Medical Sciences, Bojnurd
City
Bojnurd
Province
North Khorasan
Postal code
9416678894
Approval date
2022-02-27, 1400/12/08
Ethics committee reference number
IR.NKUMS.REC.1400.159

Health conditions studied

1

Description of health condition studied
pain
ICD-10 code
G89
ICD-10 code description
Pain, not elsewhere classified

Primary outcomes

1

Description
Level of analgesia
Timepoint
After performing spinal anesthesia technique
Method of measurement
Pin Prink method

2

Description
duration of analgesia
Timepoint
The patient's first request for an analgesic injection
Method of measurement
Researcher-made questionnaire

3

Description
Intensity of pain
Timepoint
The patient's first request for an analgesic injection
Method of measurement
visual analog scale

Secondary outcomes

1

Description
Physiological parameters (blood pressure, heart rate, mean arterial pressure)
Timepoint
After the spinal technique, for the first 15 minutes every 2 minutes and then every 4 minutes until the end of surgery
Method of measurement
Cardiac monitoring

2

Description
Drug side effects
Timepoint
End of surgery up to 24 hours later
Method of measurement
Researcher-made questionnaire

Intervention groups

1

Description
Intervention group 1: In this group of patients to perform spinal anesthesia, anesthesiologist in combination with the main anesthetic drug (bupivacaine); 10 micrograms of dexmedetomidine will be injected into the intrathecal space.
Category
Treatment - Drugs

2

Description
Intervention group 2: In this group of patients to perform spinal anesthesia, anesthesiologist in combination with the main anesthetic drug (bupivacaine); ٥ micrograms of sufentanil will be injected into the intrathecal space.
Category
Treatment - Drugs

3

Description
Control group:In this group of patients, for spinal anesthesia, the anesthesiologist will inject only the main anesthetic (bupivacaine) into the intrathecal space.
Category
Placebo

Recruitment centers

1

Recruitment center
Name of recruitment center
Emam Ali Hospital
Full name of responsible person
Javad Shahinfar
Street address
Emam Ali Hospital, Bojnurd, Iran.
City
Bojnurd
Province
North Khorasan
Postal code
9416678894
Phone
+98 58 3229 7010
Email
zeraatih@gmail.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Bojnourd University of Medical Sciences
Full name of responsible person
Amir ali Ghahremani
Street address
Vice Chancellor for Research, North Khorasan University of Medical Sciences, Bojnurd, Iran
City
Bojnurd
Province
North Khorasan
Postal code
9416678894
Phone
+98 58 3229 7010
Email
a.ghahremani@nkum.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Bojnourd University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Bojnourd University of Medical Sciences
Full name of responsible person
Hossein Zeraati
Position
Faculty member
Latest degree
Master
Other areas of specialty/work
Anesthesiology
Street address
School of Nursing and Midwifery, Shahriyar Ave, Bojnurd, Iran
City
Bojnurd
Province
North Khorasan
Postal code
9416678894
Phone
+98 58 3229 1910
Fax
Email
zeraatih@gmail.com
Web page address

Person responsible for scientific inquiries

Contact
Name of organization / entity
Bojnourd University of Medical Sciences
Full name of responsible person
Javad Shahinfar
Position
Faculty member
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
School of Nursing and Midwifery, ُShahriyar Ave, Bojnurd, Iran
City
Bojnurd
Province
North Khorasan
Postal code
9416678894
Phone
+98 58 3229 1910
Fax
Email
dr.jshahinfar@gmail.com
Web page address

Person responsible for updating data

Contact
Name of organization / entity
Bojnourd University of Medical Sciences
Full name of responsible person
Hossein Zeraati
Position
Faculty member
Latest degree
Master
Other areas of specialty/work
Anesthesiology
Street address
Collage of Nursing and midwifery, Bojnurd, iran
City
Bojnurd
Province
North Khorasan
Postal code
941668985
Phone
+98 58 3229 7010
Email
zeraatih@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
No - There is not a plan to make this available
Justification/reason for indecision/not sharing IPD
اطلاعات بیشتری وجود ندارد.
Study Protocol
No - There is not a plan to make this available
Statistical Analysis Plan
No - There is not a plan to make this available
Informed Consent Form
No - There is not a plan to make this available
Clinical Study Report
No - There is not a plan to make this available
Analytic Code
No - There is not a plan to make this available
Data Dictionary
No - There is not a plan to make this available
Loading...